Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark E Cooper

Showing results (281-290 of 399) with videos related to

Pageof 40
Sort By:
Kidney International Reports|February 22, 2021
Comparison of Circulating Biomarkers in Predicting Diabetic Kidney Disease Progression With Autoantibodies to Erythropoietin ReceptorMegumi Oshima, Akinori Hara, Tadashi Toyama, et al.
Journal of Molecular Endocrinology|August 10, 2005
High glucose-induced impairment in insulin secretion is associated with reduction in islet glucokinase in a mouse model of susceptibility to islet dysfunctionSuwattanee Kooptiwut, Melkam Kebede, Sakeneh Zraika, et al.
Circulation|April 11, 2007
Lack of the antioxidant enzyme glutathione peroxidase-1 accelerates atherosclerosis in diabetic apolipoprotein E-deficient micePaul Lewis, Nada Stefanovic, Josefa Pete, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|October 3, 2012
Experimental diabetic nephropathy is accelerated in matrix metalloproteinase-2 knockout miceYoshimi Takamiya, Kei Fukami, Sho-ichi Yamagishi, et al.
Clinical Science (London, England : 1979)|January 17, 2020
Delineating a role for the mitochondrial permeability transition pore in diabetic kidney disease by targeting cyclophilin DRuna S J Lindblom, Gavin C Higgins, Tuong-Vi Nguyen, et al.
Free Radical Biology & Medicine|July 23, 2016
NOX4-derived reactive oxygen species limit fibrosis and inhibit proliferation of vascular smooth muscle cells in diabetic atherosclerosisElyse Di Marco, Stephen P Gray, Kit Kennedy, et al.
Diabetes Care|July 8, 2017
Cardiac Stress and Inflammatory Markers as Predictors of Heart Failure in Patients With Type 2 Diabetes: The ADVANCE TrialToshiaki Ohkuma, Min Jun, Mark Woodward, et al.
Journal of the American Society of Nephrology : JASN|April 6, 2007
Albuminuria is a target for renoprotective therapy independent from blood pressure in patients with type 2 diabetic nephropathy: post hoc analysis from the Reduction of Endpoints in NIDDM with the Angiotensin II Antagonist Losartan (RENAAL) trialWouter B A Eijkelkamp, Zhongxin Zhang, Giuseppe Remuzzi, et al.
Diabetologia|February 5, 2017
Combined NOX1/4 inhibition with GKT137831 in mice provides dose-dependent reno- and atheroprotection even in established micro- and macrovascular diseaseStephen P Gray, Jay C Jha, Kit Kennedy, et al.
Cardiovascular Diabetology|January 29, 2026
Activator protein-1 (AP-1) inhibition prevents endothelial to mesenchymal transition in diabetes-associated atherosclerosis: a translational studyAbdul Waheed Khan, Misbah Aziz, Karly C Sourris, et al.
Pageof 40

Showing results (281-290 of 399) with videos related to

Sort By:
Pageof 40
Kidney International Reports|February 22, 2021
Comparison of Circulating Biomarkers in Predicting Diabetic Kidney Disease Progression With Autoantibodies to Erythropoietin ReceptorMegumi Oshima, Akinori Hara, Tadashi Toyama, et al.
Journal of Molecular Endocrinology|August 10, 2005
High glucose-induced impairment in insulin secretion is associated with reduction in islet glucokinase in a mouse model of susceptibility to islet dysfunctionSuwattanee Kooptiwut, Melkam Kebede, Sakeneh Zraika, et al.
Circulation|April 11, 2007
Lack of the antioxidant enzyme glutathione peroxidase-1 accelerates atherosclerosis in diabetic apolipoprotein E-deficient micePaul Lewis, Nada Stefanovic, Josefa Pete, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|October 3, 2012
Experimental diabetic nephropathy is accelerated in matrix metalloproteinase-2 knockout miceYoshimi Takamiya, Kei Fukami, Sho-ichi Yamagishi, et al.
Clinical Science (London, England : 1979)|January 17, 2020
Delineating a role for the mitochondrial permeability transition pore in diabetic kidney disease by targeting cyclophilin DRuna S J Lindblom, Gavin C Higgins, Tuong-Vi Nguyen, et al.
Free Radical Biology & Medicine|July 23, 2016
NOX4-derived reactive oxygen species limit fibrosis and inhibit proliferation of vascular smooth muscle cells in diabetic atherosclerosisElyse Di Marco, Stephen P Gray, Kit Kennedy, et al.
Diabetes Care|July 8, 2017
Cardiac Stress and Inflammatory Markers as Predictors of Heart Failure in Patients With Type 2 Diabetes: The ADVANCE TrialToshiaki Ohkuma, Min Jun, Mark Woodward, et al.
Journal of the American Society of Nephrology : JASN|April 6, 2007
Albuminuria is a target for renoprotective therapy independent from blood pressure in patients with type 2 diabetic nephropathy: post hoc analysis from the Reduction of Endpoints in NIDDM with the Angiotensin II Antagonist Losartan (RENAAL) trialWouter B A Eijkelkamp, Zhongxin Zhang, Giuseppe Remuzzi, et al.
Diabetologia|February 5, 2017
Combined NOX1/4 inhibition with GKT137831 in mice provides dose-dependent reno- and atheroprotection even in established micro- and macrovascular diseaseStephen P Gray, Jay C Jha, Kit Kennedy, et al.
Cardiovascular Diabetology|January 29, 2026
Activator protein-1 (AP-1) inhibition prevents endothelial to mesenchymal transition in diabetes-associated atherosclerosis: a translational studyAbdul Waheed Khan, Misbah Aziz, Karly C Sourris, et al.
Pageof 40